Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/2011
03/03/2011US20110052502 MicroRNA Signatures Associated with Human Chronic Lymphocytic Leukemia (CCL) and Uses Thereof
03/03/2011US20110052500 TAJ in Neuronal Function
03/03/2011US20110052499 Baboon homolog of human cd147
03/03/2011US20110052496 Hollow nanoparticles and uses thereof
03/03/2011US20110052494 H-antigen binding polypeptides and methods of use
03/03/2011US20110048437 Tobacco nicotine demethylase genomic clone and uses thereof
03/03/2011DE112009001080T5 Verfahren zum Herstellen von β-Alanylaminosäure oder eines Derivats davon A process for producing β-alanyl-amino acid or a derivative thereof
03/03/2011DE102009037331A1 Verfahren zur Separierung von Partikeln und/oder Zellen mit 2 und mehr Oberflächenspezifitäten A process for the separation of particles and / or cells with 2 or more surface specificities
03/03/2011CA2771927A1 Proteins relating to grain shape and leaf shape of rice, coding genes and uses thereof
03/03/2011CA2771781A1 Antikine antibodies that bind to multiple cc chemokines
03/03/2011CA2771755A1 Modified transgene encoding a growth and/or development related protein in plants
03/03/2011CA2769879A1 Polynucleotide derived from novel hepatitis c virus strain and use thereof
03/03/2011CA2761231A1 Imaging and evaluating embryos, oocytes, and stem cells
03/02/2011EP2290090A1 Methods for stable transformation of plants
03/02/2011EP2290079A2 Neurotrophic factors
03/02/2011EP2290077A2 Natural IGM antibodies and inhibitors thereof
03/02/2011EP2290065A1 Process for production of cis-4-hydroxy-l-proline
03/02/2011EP2290062A1 Corynebacterium glutamicum gene encoding phosphoenolpyruvate carboxykinase
03/02/2011EP2290060A1 Alpha-amylase variants
03/02/2011EP2290059A1 Lipolytic enzyme variants
03/02/2011EP2290058A1 Lipolytic enzyme variants
03/02/2011EP2290056A2 Mutated Abl kinase domains
03/02/2011EP2290053A1 Method for producing Influenza virus in protein-free cell culture medium
03/02/2011EP2290052A1 Extracellular matrix coated surface for culturing cells
03/02/2011EP2289943A1 Antibody capable of discriminating the change in structure between antibody conjugated with antibody and antibody unconjugated with antibody, and method for production of the antibody
03/02/2011EP2289940A2 Treatment of metastatic disease
03/02/2011EP2289939A2 PAN-KIR2DL NK-receptor antibodies and their use in diagnostik and therapy
03/02/2011EP2289910A2 Differential in tumour gene products and use of same
03/02/2011EP2289567A2 Matrix comprising naturally-occurring crosslinked protein backbone
03/02/2011EP2289552A1 An immunosuppressive agent plus anti-TCR antibodies for the induction of chimerism in transplantation
03/02/2011EP2289531A2 Medicaments for increasing endogenous erythropoietine (EPO)
03/02/2011EP2289526A1 Muscle derived cells (MDCs) for promoting and enhancing nerve repair and regeneration.
03/02/2011EP2289525A1 Use of IL-21 for expanding lymphoid cells and for anticancer adoptive immunotherapy
03/02/2011EP2288700A1 Hbv epitope reactive exogenous t cell receptor (tcr) and uses thereof
03/02/2011EP2288695A1 Pluripotency associated epigenetic factor
03/02/2011EP2288693A1 Novel astrovirus
03/02/2011EP2288692A1 Method of efficiently establishing induced pluripotent stem cells
03/02/2011EP2288691A1 Cellular differentiation process and its use for blood vessel build-up
03/02/2011EP2288690A2 Methods for producing enucleated erythroid cells derived from pluripotent stem cells
03/02/2011EP2288624A2 Compositions and methods for inhibiting shiga toxin and shiga-like toxin
03/02/2011EP2288623A2 Method of generating single vl domain antibodies in transgenic animals
03/02/2011EP2288359A1 Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents
03/02/2011EP2288253A1 New method for the production of somatic embryos from euphorbia pulcherrima plant tissue
03/02/2011EP1934258B1 Antibodies against april as biomarkers for early prognosis of lymphoma patients
03/02/2011EP1885382B1 Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
03/02/2011EP1819290B1 Scaffoldless constructs for tissue engineering of articular cartilage
03/02/2011EP1767622B1 Transgenic cell for assay of dioxin and utilizing the same, dioxin detecting method and biosensor
03/02/2011EP1650225B1 Hetero type pentamer recombinant vaccine
03/02/2011EP1640716B1 Blood cell separation membrane and blood retention tool including the same
03/02/2011EP1513937B1 A method for the stimultaneaous production of multiple proteins; vectors and cells for use therein
03/02/2011EP1456390B1 Expression of protective antigens in transgenic chloroplasts and the production of improved vaccines
03/02/2011EP1416880B1 Cartilage repair apparatus
03/02/2011EP1368456B1 Anti-bacterial vaccine compositions
03/02/2011EP1287123B1 Subtilisin variant
03/02/2011CN1774500B An expression cassette and vector for transient or stable expression of exogenous molecules
03/02/2011CN1748034B Improved expression element
03/02/2011CN1714150B Genetic products differentially expressed in tumors and the use thereof
03/02/2011CN1507490B Promoters
03/02/2011CN101983007A Method of producing transformed plant by using agrobacterium strain
03/02/2011CN101982545A Molecular marker SIsv0053 closely linked with millet plant height genes
03/02/2011CN101413012B Method for inducing differentiation of mesenchyma stem cell into islet beta-like cells, and use thereof
03/01/2011USRE42191 Methods for the preparation, isolation and purification of epothilone B, and X-ray crystal structures of epothilone B
03/01/2011USRE42190 Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors
03/01/2011US7897855 Maize variety PHWHE
03/01/2011US7897851 Barley cultivar ‘YU599-012’
03/01/2011US7897849 Soybean cultivar 7802136
03/01/2011US7897845 Wheat plants having increased resistance to imidazolinone herbicides
03/01/2011US7897844 PUFA polyketide synthase systems and uses thereof
03/01/2011US7897843 Expression vector comprising nucleotide sequences coding plant transcription factor for use in transformation and generation of heat, drought, salt and freeze resistant crop plants
03/01/2011US7897842 GnTIII expression in plants
03/01/2011US7897840 Salt responsive genes useful for generating salt resistant transgenic plants
03/01/2011US7897839 Methods for modifying plant characteristics
03/01/2011US7897837 Generation of plants with improved pathogen resistance
03/01/2011US7897760 Comprises transgenic potato which generates starch with modified viscosity and phosphate characteristics; for enhancing quality of paper, cardboard, adhesive, textile, plaster, concrete, fertilizer, medicine and toothpaste; improving animal feeds
03/01/2011US7897738 DNA polymerases having improved labeled nucleotide incorporation properties
03/01/2011US7897733 Rapamycin conjugates and antibodies
03/01/2011US7897732 Useful in methods for the induction of bone, cartilage and tissue formation, growth and development of the endometrium and in the acceleration of wound healing
03/01/2011US7897726 Fluorescent proteins from Aequorea coerulscens and methods for using the same
03/01/2011US7897588 Agents and methods for enhancing bone formation
03/01/2011US7897397 Cell fusion promoter and utilization of the same
03/01/2011US7897394 Endoplasmic reticulum localization signals
03/01/2011US7897393 PUFA polyketide synthase systems and uses thereof
03/01/2011US7897392 Nucleic acid with FabA-like beta -hydroxyacyl-ACP dehydrase (DH) activity biosynthesis of polyunsaturated fatty acids (PUFAs)
03/01/2011US7897391 PUFA polyketide synthase systems and uses thereof
03/01/2011US7897390 Cell culture system
03/01/2011US7897389 Direct differentiation method for making cardiomyocytes from human embryonic stem cells
03/01/2011US7897388 Growth of neural precursor cells using umbilical cord blood serum and a process for the preparation for therapeutic purposes
03/01/2011US7897386 Cell-based assays for G-protein-coupled receptor-mediated activities
03/01/2011US7897385 Fluorescent protein
03/01/2011US7897384 Chondrocyte therapeutic delivery system
03/01/2011US7897383 Recombinant constructs and their use in reducing gene expression
03/01/2011US7897380 Circular nucleic acid vectors, and methods for making and using the same
03/01/2011US7897379 Device and method for reducing bubble formation in cell culture
03/01/2011US7897370 Process for producing HMG-CoA reductase inhibitor
03/01/2011US7897365 Method for adjusting antibiotic sensitivity of a test culture
03/01/2011US7897351 Peptides and antibodies to MUC 1 proteins
03/01/2011US7897335 Detection of preferential proteins in sample; obtain sample nucleotide sequences, dilute, amplify sequences, translate, test for proteins
03/01/2011US7897332 Immunoglobulin for detecting lymphadenopathy associated viral infections; immunodiagnostics
03/01/2011US7897165 Covalent binding of a hydrogel to an extracellular matrix; primed extracellular matrix comprises tyrosyl radicals, polymerizable agent is an acrylate; tissue repair, delivery of drugs or cells
03/01/2011US7897158 Recombinant toxin fragments